ASTARTE + CELLERO SUCCESS STORY
Unlocking Potential:
Leading a vital biotech company through rapid growth to a $38M acquisition.
growth attributed to marketing
645%
marketing ROI
Strategy, content, website…go
The leadership of Astarte Biologics knew their immune cell products company needed a leg up on the competition.
They brought in our full-service marketing agency with deep experience in biotechnology and life sciences to accelerate growth.
As Astarte’s outsourced marketing department, we launched a three-year marketing strategy and built an e-commerce store and sophisticated inventory management system.
Industry: Biotech
Size: Mid-market
Astarte-Cellero Growth Story
The growth journey
Using educational content, SEO, LinkedIn Ads, and email cadences, we launched brand awareness and lead generation campaigns with best-in-class attribution.
"They grew our business by 4x with no sales team!"
Clarity Quest grew our business by 4x in just four years... and we didn't have a sales team! I enjoy the enthusiasm and knowledge of the CQ team and trust them implicitly for all things marketing.
Anne Lodge, Principal | Astarte Biologics/Cellero
Merger
In 2018, Astarte merged Memphis-based Key Biologics, a supplier of leukapheresis products and related collection services. The combined entity selected us to define their go-to-market branding and communication strategy.
Ignite,Accelerate,Discover,Cures
Unlocking Cures
Leveraging our subject matter expertise as life science marketers, we developed a comprehensive messaging and positioning platform.
We named the new entity, created a tagline, and brought the brand to life with stunning visuals and award-winning website design.
Cellero was born.
"We have an amazing new brand thanks to your leadership."
I just want to express my gratitude for all the work the CQ team put into getting us to launch. We are all very excited about our new brand, and appreciate your team’s leadership and facilitation of brand design and messaging. It is very rewarding to have a unifying brand for our team and our stakeholders to rally around. Thank you!
Jeffrey D. Allen, President & CEO | Cellero
$38 million acquisition
The Cellero brand launch and aggressive expansion plans raised eyebrows across the industry. In 2020, Charles River Laboratories International (NYSE: CRL) acquired Cellero for approximately $38 million in cash.
“The addition of Cellero will enhance Charles River’s unique, comprehensive solutions for the high-growth cell therapy market, strengthening its ability to help accelerate clients’ critical programs from basic research and proof-of-concept to regulatory approval and commercialization.”
Charles River Laboratories | SEC Filing